A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MBRX shares is 32, representing 10.50% of the company's common stock.

BLACKROCK INC., in the last quarter, reduced its stake in MBRX by -0.81% restricting it's holding to 262.89 Thousands shares of worth nearly $278 Thousands. RENAISSANCE TECHNOLOGIES LLC also lessened -4.09% of the MBRX shares from its portfolio, reducing its holding to 84.5 Thousands shares of worth $90 Thousands. N/A also shunned MBRX shares holding by N/A last quarter which brought its holding to 0 shares worth $0.

As per its latest 13F filing, VANGUARD GROUP INC increased its stake in MBRX by 0% in the last quarter. The institutional holder raised its holding to 1.08 Million shares having worth more than $1.14 Million. SIO CAPITAL MANAGEMENT, LLC also added 0% more shares of MBRX to its portfolio, raising its holding to 1.04 Million shares of worth $1.1 Million. GEODE CAPITAL MANAGEMENT, LLC also increased its MBRX shares holding by 0% which brought its holding to 247.05 Thousands shares worth $261 Thousands.

The insider with the most stakes in MBRX is PRIEBE WALDEMAR , a 10 percent owner at the company. Additionally, MBRX stock is highly held by CEO and President KLEMP WALTER V and Chief Financial Officer FOSTER JONATHAN P. among others.

Company executives, directors, and other insiders own 1.4 percent of Moleculin Biotech, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which MBRX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include

There have been 4 transaction(s) during the past 6-months in which MBRX insiders have bought stock , totaling $177,455.

Around 400.82 Thousands Moleculin Biotech, Inc. shares are held by insiders, which represents about 1.40% of MBRX Stock.

MBRX 10 percent owner, PRIEBE WALDEMAR holds the largest portfolio of the company's shares. MBRX shares owned by Levinson total nearly 2.78 Million.

VANGUARD GROUP INC is the largest institutional owner in MBRX which holds 1.08 Million shares worth $1.14 Million or 4.02% of the total MBRX shares outstanding followed by SIO CAPITAL MANAGEMENT, LLC with ownership of 1.04 Million shares representing 3.86% of the MBRX ownership. BLACKROCK INC., Inc is the third largest stakeholder with 262.89 Thousands shares or 0.98% of the ownership worth more than $278 Thousands.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MBRX is concerned, it is a stock which is not optionable.

Number of MBRX shares short as of 2023-01-30 was 39.39 Thousands. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 28.63 Million shares of MBRX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MBRX has 27.79 Million shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MBRX was N/A as of 2023-01-30.